Drug Shortage Report for MYLAN-ATORVASTATIN

Last updated on 2018-10-24 History
Report ID 19456
Drug Identification Number 02392976
Brand name MYLAN-ATORVASTATIN
Common or Proper name ATORVASTATIN
Company Name MYLAN PHARMACEUTICALS ULC
Active Ingredient(s) ATORVASTATIN
Strength(s) 80MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 90BT, 500BT
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-10-20
Actual start date
Estimated end date 2018-10-26
Actual end date 2018-10-23
Shortage status Resolved
Updated date 2018-10-24
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v78 2018-10-24 English Compare
v77 2018-10-23 French Compare
v76 2018-10-23 English Compare
v75 2018-10-21 English Compare
v74 2018-10-19 French Compare
v73 2018-10-19 English Compare
v72 2018-10-19 English Compare
v71 2018-10-17 French Compare
v70 2018-10-17 English Compare
v69 2018-10-17 English Compare
v68 2018-10-16 French Compare
v67 2018-10-16 English Compare
v66 2018-10-11 English Compare
v65 2018-10-09 French Compare
v64 2018-10-09 English Compare
v63 2018-10-01 French Compare
v62 2018-10-01 English Compare
v61 2018-09-24 French Compare
v60 2018-09-24 English Compare
v59 2018-09-21 English Compare

Showing 1 to 20 of 78